Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Serotonin-endocannabinoid crosstalk selectively regulates inhibitory GABAergic inputs in the medial prefrontal cortex
    Published on 2026-02-10
    4 months ago
  • The sodium leak channel NALCN in Drd2+ striatal neurons regulates neuronal excitability, locomotion and food-seeking in a sex-dependent manner
    Published on 2026-02-10
    4 months ago
  • Galanin receptor 1 expressing neurons in hippocampal-prefrontal circuitry modulate goal directed attention and impulse control
    Published on 2026-02-10
    4 months ago
  • Moderators of treatment response in late-life depression
    Published on 2026-02-09
    4 months ago
  • Neuropsychiatric illness in the later years of life: summary and synthesis
    Published on 2026-02-09
    4 months ago
  • Prevention of late-life depression: a framework and prospectus for research
    Published on 2026-02-09
    4 months ago
  • Caffeine reverses sleep deprivation-induced synaptic and social memory deficits via adenosine receptor modulation in the male mouse hippocampal CA2 region
    Published on 2026-02-09
    4 months ago
« Previous 1 … 12 13 14 15 16 … 143 Next »
Journal of Psychopharmacology
  • Statistical limitations of the claimed dose–response in “Dose–response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials”
    Published on 2025-11-27
    6 months ago
  • Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: A randomized, double-blind, placebo-controlled clinical trial
    Published on 2025-11-24
    6 months ago
  • Long-term neurocognitive side effects of MDMA in recreational ecstasy users following sustained abstinence: A systematic review and meta-analysis
    Published on 2025-11-19
    6 months ago
  • Role of chemokines in depression: Highlights on CX3CL1/CX3CR1 signaling
    Published on 2025-11-17
    6 months ago
  • Antidepressant initiation and the risk of treatment-emergent mania in children and adolescents with depression: A real-world cohort study
    Published on 2025-11-12
    7 months ago
  • Facing trauma under the influence of psychedelics: A phenomenological study with Nova rave survivors
    Published on 2025-11-11
    7 months ago
  • Effects of a Scutellaria baicalensis/Crataegus laevigata, magnesium and chromium supplement on stressed individuals: A randomised, double-blind, placebo-controlled, crossover trial
    Published on 2025-11-06
    7 months ago
« Previous 1 … 12 13 14 15 16 … 146 Next »
European Neuropsychopharmacology
  • Psychedelics: The pathway to implementation in the European healthcare systems
    Published on 2025-12-03
    6 months ago
  • Exploring clozapine dose adjustment strategy in acute-phase reaction of inflammation based on free drug concentrations and Kpuu
    Published on 2025-11-27
    6 months ago
  • Corrigendum to “Does bipolar disorder accelerate cellular aging? A systematic review and meta-analysis of telomere length” [European Neuropsychopharmacology; 2025;99:21-30]
    Published on 2025-11-26
    6 months ago
  • Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach
    Published on 2025-11-26
    6 months ago
  • Editorial Board
    Published on 2025-11-25
    6 months ago
  • Three shades of gloom: investigating the genetic background of current depressive symptoms associated with different severity of current stress exposure in a general population
    Published on 2025-11-24
    6 months ago
  • Reply to the commentary on “Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”
    Published on 2025-11-23
    6 months ago
« Previous 1 … 12 13 14 15 16 … 166 Next »

   Pharma Pub